Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream, 0.005%
capital market | Mumbai | June 11, 2015 09:25 IST
Glenmark Pharmaceuticals has been granted final approval by the United State Food & Drug Adminstration for Calcipotriene Cream, 0.005%, the therapeutic equivalent of Dovonex Cream, 0.005% of Leo Pharma A/S. Glenmark plans to commence shipping of Calcipotriene Cream, 0.005% immediately.
Powered by Capital Market - Live News